Clinical standards for the assessment, management and rehabilitation of post-TB lung disease

Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD and the implementation of pulmonary rehabilitation (PR). A panel of global experts in the fiel...

Full description

Saved in:

Bibliographic Details
Published in:	The international journal of tuberculosis and lung disease Vol. 25; no. 10; p. 797
Main Authors:	Migliori, G B, Marx, F M, Ambrosino, N, Zampogna, E, Schaaf, H S, van der Zalm, M M, Allwood, B, Byrne, A L, Mortimer, K, Wallis, R S, Fox, G J, Leung, C C, Chakaya, J M, Seaworth, B, Rachow, A, Marais, B J, Furin, J, Akkerman, O W, Al Yaquobi, F, Amaral, A F S, Borisov, S, Caminero, J A, Carvalho, A C C, Chesov, D, Codecasa, L R, Teixeira, R C, Dalcolmo, M P, Datta, S, Dinh-Xuan, A-T, Duarte, R, Evans, C A, García-García, J-M, Günther, G, Hoddinott, G, Huddart, S, Ivanova, O, Laniado-Laborín, R, Manga, S, Manika, K, Mariandyshev, A, Mello, F C Q, Mpagama, S G, Muñoz-Torrico, M, Nahid, P, Ong, C W M, Palmero, D J, Piubello, A, Pontali, E, Silva, D R, Singla, R, Spanevello, A, Tiberi, S, Udwadia, Z F, Vitacca, M, Centis, R, D Ambrosio, L, Sotgiu, G, Lange, C, Visca, D
Format:	Journal Article
Language:	English
Published:	France 01.10.2021
Subjects:	Consensus Humans Lung Diseases - diagnosis Lung Diseases - therapy Quality of Life Tuberculosis - complications
ISSN:	1815-7920, 1815-7920
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD and the implementation of pulmonary rehabilitation (PR). A panel of global experts in the field of TB care and PR was identified; 62 participated in a Delphi process. A 5-point Likert scale was used to score the initial ideas for standards and after several rounds of revision the document was approved (with 100% agreement). Five clinical standards were defined: Standard 1, to assess patients at the end of TB treatment for PTLD (with adaptation for children and specific settings/situations); Standard 2, to identify patients with PTLD for PR; Standard 3, tailoring the PR programme to patient needs and the local setting; Standard 4, to evaluate the effectiveness of PR; and Standard 5, to conduct education and counselling. Standard 6 addresses public health aspects of PTLD and outcomes due to PR. This is the first consensus-based set of Clinical Standards for PTLD. Our aim is to improve patient care and quality of life by guiding clinicians, programme managers and public health officers in planning and implementing adequate measures to assess and manage PTLD.
AbstractList	Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD and the implementation of pulmonary rehabilitation (PR). A panel of global experts in the field of TB care and PR was identified; 62 participated in a Delphi process. A 5-point Likert scale was used to score the initial ideas for standards and after several rounds of revision the document was approved (with 100% agreement). Five clinical standards were defined: Standard 1, to assess patients at the end of TB treatment for PTLD (with adaptation for children and specific settings/situations); Standard 2, to identify patients with PTLD for PR; Standard 3, tailoring the PR programme to patient needs and the local setting; Standard 4, to evaluate the effectiveness of PR; and Standard 5, to conduct education and counselling. Standard 6 addresses public health aspects of PTLD and outcomes due to PR. This is the first consensus-based set of Clinical Standards for PTLD. Our aim is to improve patient care and quality of life by guiding clinicians, programme managers and public health officers in planning and implementing adequate measures to assess and manage PTLD. BACKGROUND: Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD and the implementation of pulmonary rehabilitation (PR).METHODS: A panel of global experts in the field of TB care and PR was identified; 62 participated in a Delphi process. A 5-point Likert scale was used to score the initial ideas for standards and after several rounds of revision the document was approved (with 100% agreement).RESULTS: Five clinical standards were defined: Standard 1, to assess patients at the end of TB treatment for PTLD (with adaptation for children and specific settings/situations); Standard 2, to identify patients with PTLD for PR; Standard 3, tailoring the PR programme to patient needs and the local setting; Standard 4, to evaluate the effectiveness of PR; and Standard 5, to conduct education and counselling. Standard 6 addresses public health aspects of PTLD and outcomes due to PR.CONCLUSION: This is the first consensus-based set of Clinical Standards for PTLD. Our aim is to improve patient care and quality of life by guiding clinicians, programme managers and public health officers in planning and implementing adequate measures to assess and manage PTLD.BACKGROUND: Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD and the implementation of pulmonary rehabilitation (PR).METHODS: A panel of global experts in the field of TB care and PR was identified; 62 participated in a Delphi process. A 5-point Likert scale was used to score the initial ideas for standards and after several rounds of revision the document was approved (with 100% agreement).RESULTS: Five clinical standards were defined: Standard 1, to assess patients at the end of TB treatment for PTLD (with adaptation for children and specific settings/situations); Standard 2, to identify patients with PTLD for PR; Standard 3, tailoring the PR programme to patient needs and the local setting; Standard 4, to evaluate the effectiveness of PR; and Standard 5, to conduct education and counselling. Standard 6 addresses public health aspects of PTLD and outcomes due to PR.CONCLUSION: This is the first consensus-based set of Clinical Standards for PTLD. Our aim is to improve patient care and quality of life by guiding clinicians, programme managers and public health officers in planning and implementing adequate measures to assess and manage PTLD.
Author	Udwadia, Z F Dalcolmo, M P Pontali, E Duarte, R Seaworth, B Carvalho, A C C Schaaf, H S Laniado-Laborín, R Chakaya, J M Evans, C A Muñoz-Torrico, M Huddart, S Manika, K Singla, R Palmero, D J Codecasa, L R Vitacca, M Ivanova, O Piubello, A Caminero, J A Borisov, S Datta, S Mortimer, K Centis, R Teixeira, R C Ong, C W M Al Yaquobi, F Ambrosino, N Chesov, D Amaral, A F S Furin, J Silva, D R Visca, D Hoddinott, G Fox, G J Nahid, P D Ambrosio, L Zampogna, E Manga, S Spanevello, A Marais, B J Allwood, B Akkerman, O W Migliori, G B Rachow, A García-García, J-M van der Zalm, M M Marx, F M Wallis, R S Mpagama, S G Günther, G Mariandyshev, A Mello, F C Q Tiberi, S Dinh-Xuan, A-T Byrne, A L Lange, C Sotgiu, G Leung, C C
Author_xml	– sequence: 1 givenname: G B surname: Migliori fullname: Migliori, G B organization: Respiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy – sequence: 2 givenname: F M surname: Marx fullname: Marx, F M organization: Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, DSI-NRF South African Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa – sequence: 3 givenname: N surname: Ambrosino fullname: Ambrosino, N organization: Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri IRCCS, Montescano (PV), Italy – sequence: 4 givenname: E surname: Zampogna fullname: Zampogna, E organization: Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy – sequence: 5 givenname: H S surname: Schaaf fullname: Schaaf, H S organization: Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa – sequence: 6 givenname: M M surname: van der Zalm fullname: van der Zalm, M M organization: Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa – sequence: 7 givenname: B surname: Allwood fullname: Allwood, B organization: Division of Pulmonology, Department of Medicine, Stellenbosch University & Tygerberg Hospital, South Africa – sequence: 8 givenname: A L surname: Byrne fullname: Byrne, A L organization: Heart Lung Clinic St Vincent´s Hospital and Clinical School, University of New South Wales, Sydney, NSW, Australia, Partners In Health (Socios En Salud Sucursal), Lima, Peru – sequence: 9 givenname: K surname: Mortimer fullname: Mortimer, K organization: Liverpool School of Tropical Medicine, Liverpool, UK – sequence: 10 givenname: R S surname: Wallis fullname: Wallis, R S organization: Aurum Institute, Johannesburg, South Africa – sequence: 11 givenname: G J surname: Fox fullname: Fox, G J organization: Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia – sequence: 12 givenname: C C surname: Leung fullname: Leung, C C organization: Hong Kong Tuberculosis, Chest and Heart Diseases Association, Hong Kong – sequence: 13 givenname: J M surname: Chakaya fullname: Chakaya, J M organization: Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK – sequence: 14 givenname: B surname: Seaworth fullname: Seaworth, B organization: Heartland National TB Center of Excellence, San Antonio, TX, University of Texas Health Science Center, Tyler, TX, USA – sequence: 15 givenname: A surname: Rachow fullname: Rachow, A organization: Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany, German Center for Infection Research (DZIF), Partner Site Munich, Germany – sequence: 16 givenname: B J surname: Marais fullname: Marais, B J organization: The Children´s Hospital at Westmead and the University of Sydney WHO Collaborating Center in Tuberculosis, University of Sydney, Sydney, NSW, Australia – sequence: 17 givenname: J surname: Furin fullname: Furin, J organization: Harvard Medical School, Department of Global Health and Social Medicine, Boston, MA, USA – sequence: 18 givenname: O W surname: Akkerman fullname: Akkerman, O W organization: University of Groningen, University Medical Center Groningen, department of Pulmonary diseases and Tuberculosis, Groningen, the Netherlands, University of Groningen, University Medical Center Groningen, TB center Beatrixoord, Groningen, the Netherlands – sequence: 19 givenname: F surname: Al Yaquobi fullname: Al Yaquobi, F organization: TB and Acute Respiratory Diseases Section, Department of Communicable Diseases, Directorate General of Disease Surveillance and Control, Ministry of Health, Oman – sequence: 20 givenname: A F S surname: Amaral fullname: Amaral, A F S organization: National Heart and Lung Institute, Imperial College London, London, UK – sequence: 21 givenname: S surname: Borisov fullname: Borisov, S organization: Moscow Research and Clinical Center for Tuberculosis Control, Moscow Health Department, Moscow, Russian Federation – sequence: 22 givenname: J A surname: Caminero fullname: Caminero, J A organization: Mycobacterial Unit, Pneumology Department. University General Hospital of Gran Canaria "Dr. Negrin", Las Palmas, Gran Canaria, ALOSA TB Academy, Spain – sequence: 23 givenname: A C C surname: Carvalho fullname: Carvalho, A C C organization: Laboratório de Inovações em Terapias, Ensino e Bioprodutos (LITEB), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil – sequence: 24 givenname: D surname: Chesov fullname: Chesov, D organization: Department of Pneumology and Allergology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany – sequence: 25 givenname: L R surname: Codecasa fullname: Codecasa, L R organization: TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy – sequence: 26 givenname: R C surname: Teixeira fullname: Teixeira, R C organization: National Institute of Respiratory Diseases and the Environment (INERAM), Asunción, Paraguay, Radboud University Medical Center, TB Expert Center Dekkerswald, Department of Respiratory Diseases, Nijmegen - Groesbeek, The Netherlands – sequence: 27 givenname: M P surname: Dalcolmo fullname: Dalcolmo, M P organization: Reference Center Hélio Fraga, Fundação Oswaldo Cruz (Fiocruz), Ministry of Health, Rio de Janeiro, RJ, Brazil – sequence: 28 givenname: S surname: Datta fullname: Datta, S organization: Department of clinical sciences, Liverpool School of Tropical Medicine, Liverpool, UK, Innovation For Health And Development (IFHAD) Laboratory for Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru, Innovacion Por la Salud Yel Desarollo, (IPSYD) Asociación Benéfica PRISMA, Lima, Peru – sequence: 29 givenname: A-T surname: Dinh-Xuan fullname: Dinh-Xuan, A-T organization: Université de Paris, APHP Centre, Lung Function Unit, Department of Respiratory Diseases, Cochin Hospital, Paris, France – sequence: 30 givenname: R surname: Duarte fullname: Duarte, R organization: Institute of Public Health, Porto University; Medical School, Porto University; Hospital Centre of Vila Nova de Gaia/Espinho, Porto, Portugal – sequence: 31 givenname: C A surname: Evans fullname: Evans, C A organization: Innovation For Health And Development (IFHAD) Laboratory for Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru, Innovacion Por la Salud Yel Desarollo, (IPSYD) Asociación Benéfica PRISMA, Lima, Peru, Department of Infectious Diseases, Imperial College London, London, UK – sequence: 32 givenname: J-M surname: García-García fullname: García-García, J-M organization: Tuberculosis Research Programme SEPAR, Barcelona, Spain – sequence: 33 givenname: G surname: Günther fullname: Günther, G organization: Department of Pulmonology, Inselspital Bern, University of Bern, Switzerland – sequence: 34 givenname: G surname: Hoddinott fullname: Hoddinott, G organization: Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa – sequence: 35 givenname: S surname: Huddart fullname: Huddart, S organization: UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, UCSF Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA – sequence: 36 givenname: O surname: Ivanova fullname: Ivanova, O organization: Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany, German Center for Infection Research (DZIF), Partner Site Munich, Germany – sequence: 37 givenname: R surname: Laniado-Laborín fullname: Laniado-Laborín, R organization: Clínica de Tuberculosis, Hospital General Tijuana, Universidad Autónoma De Baja California, Mexico – sequence: 38 givenname: S surname: Manga fullname: Manga, S organization: Medecins Sans Frontieres (MSF), Operational Center, Paris, France – sequence: 39 givenname: K surname: Manika fullname: Manika, K organization: Pulmonary Department, Aristotle University of Thessaloniki, "G. Papanikolaou" Hospital, Thessaloniki, Greece – sequence: 40 givenname: A surname: Mariandyshev fullname: Mariandyshev, A organization: Northern State Medical University, Northern Arctic Federal University, Arkhangelsk, Russian Federation – sequence: 41 givenname: F C Q surname: Mello fullname: Mello, F C Q organization: Thoracic Diseases Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil – sequence: 42 givenname: S G surname: Mpagama fullname: Mpagama, S G organization: Kibong´oto Infectious Diseases Hospital, Kilimanjaro Christian Medical University College, Moshi Kilimanjaro, Tanzania – sequence: 43 givenname: M surname: Muñoz-Torrico fullname: Muñoz-Torrico, M organization: Tuberculosis Clinic, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City – sequence: 44 givenname: P surname: Nahid fullname: Nahid, P organization: UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, UCSF Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA – sequence: 45 givenname: C W M surname: Ong fullname: Ong, C W M organization: Infectious Disease Translational Research Programme, Department of Medicine, National University of Singapore, Yong Loo Lin School of Medicine, Singapore, National University of Singapore Institute for Health Innovation & Technology (iHealthtech), Singapore – sequence: 46 givenname: D J surname: Palmero fullname: Palmero, D J organization: Pulmonology Division, Municipal Hospital F.J. Muñiz and Instituto Vaccarezza, Buenos Aires, Argentina – sequence: 47 givenname: A surname: Piubello fullname: Piubello, A organization: Damien Foundation, Brussels, Belgium – sequence: 48 givenname: E surname: Pontali fullname: Pontali, E organization: Department of Infectious Diseases, Galliera Hospital, Genoa, Italy – sequence: 49 givenname: D R surname: Silva fullname: Silva, D R organization: Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil – sequence: 50 givenname: R surname: Singla fullname: Singla, R organization: Department of TB and Respiratory Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India – sequence: 51 givenname: A surname: Spanevello fullname: Spanevello, A organization: Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy, Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Tradate, Varese-Como, Italy – sequence: 52 givenname: S surname: Tiberi fullname: Tiberi, S organization: Department of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK, Blizard Institute, Queen Mary University of London, London, UK – sequence: 53 givenname: Z F surname: Udwadia fullname: Udwadia, Z F organization: Department of Respiratory Medicine, Hinduja Hospital & Research Center, Mumbai, India – sequence: 54 givenname: M surname: Vitacca fullname: Vitacca, M organization: Respiratory Unit, Istituti Clinici Scientifici Maugeri IRCCS, Lumezzane (BS), Italy – sequence: 55 givenname: R surname: Centis fullname: Centis, R organization: Respiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy – sequence: 56 givenname: L surname: D Ambrosio fullname: D Ambrosio, L organization: Public Health Consulting Group, Lugano, Switzerland – sequence: 57 givenname: G surname: Sotgiu fullname: Sotgiu, G organization: Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy – sequence: 58 givenname: C surname: Lange fullname: Lange, C organization: Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany, German Center for Infection Research (DZIF), Clinical Tuberculosis Unit, Borstel, Germany, Respiratory Medicine and International Health, University of Lübeck, Lübeck, Germany – sequence: 59 givenname: D surname: Visca fullname: Visca, D organization: Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy, Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Tradate, Varese-Como, Italy
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/34615577$$D View this record in MEDLINE/PubMed
BookMark	eNpNkDtPwzAUhS1URB8wsiKPDKT4nWSEipdUiaVsSNFNc926cpwSOwP_vkUUiel8w6ejozMlo9AFJOSas7nWRXHvdsk3c8HnTAl9Ria84DrLS8FG_3hMpjHuGBOc8_yCjKUyXOs8n5DPhXfBrcHTmCA00DeR2q6naYsUYsQYWwzpjrYQYIM_TI8a7XELtfMuQXJdoJ2l-y6mbPVI_RA2tHERIeIlObfgI16dckY-np9Wi9ds-f7ytnhYZmuVm5SB1qUpa9kggC0gx6JmKNEwVQjkyFUNFiweF4M1KKWSpUHFbckbhVzmYkZuf3v3ffc1YExV6-IavYeA3RAroQvGuDFKHtWbkzrULTbVvnct9N_V3yPiAFR9Zbo
CitedBy_id	crossref_primary_10_1164_rccm_202402_0374SO crossref_primary_10_1055_a_1934_8303 crossref_primary_10_1136_bmjopen_2024_094118 crossref_primary_10_1183_13993003_00109_2024 crossref_primary_10_1183_13993003_00950_2023 crossref_primary_10_1016_S2213_2600_24_00085_7 crossref_primary_10_1183_13993003_00925_2023 crossref_primary_10_1016_S1473_3099_24_00136_1 crossref_primary_10_1016_j_cbi_2023_110817 crossref_primary_10_3390_antibiotics10111355 crossref_primary_10_1371_journal_pgph_0004935 crossref_primary_10_3390_antibiotics12121733 crossref_primary_10_1016_j_tube_2022_102244 crossref_primary_10_1093_infdis_jiaf069 crossref_primary_10_3390_antibiotics12010166 crossref_primary_10_1016_j_pulmoe_2023_05_008 crossref_primary_10_1016_j_ijid_2022_03_026 crossref_primary_10_1016_j_arbres_2025_03_001 crossref_primary_10_3389_fpubh_2024_1431881 crossref_primary_10_1002_ajim_23460 crossref_primary_10_7759_cureus_64904 crossref_primary_10_1183_13993003_00216_2024 crossref_primary_10_1016_j_jctube_2025_100542 crossref_primary_10_1016_j_pulmoe_2022_01_018 crossref_primary_10_25259_JPATS_43_2022 crossref_primary_10_1080_24745332_2022_2036504 crossref_primary_10_1111_myc_13711 crossref_primary_10_1186_s12913_023_09835_4 crossref_primary_10_1093_cid_ciad290 crossref_primary_10_1016_S1473_3099_23_00375_4 crossref_primary_10_1093_ije_dyaf033 crossref_primary_10_1016_j_prrv_2024_07_001 crossref_primary_10_1183_16000617_0221_2022 crossref_primary_10_1186_s12879_023_08375_w crossref_primary_10_1136_thorax_2024_222350 crossref_primary_10_7759_cureus_63420 crossref_primary_10_1016_S2214_109X_25_00114_7 crossref_primary_10_1016_S2213_2600_22_00099_6 crossref_primary_10_30789_rcneumologia_v37_n1_2025_1264 crossref_primary_10_52692_1857_0011_2021_3_71_31 crossref_primary_10_5588_ijtldopen_23_0587 crossref_primary_10_1177_14799731251345492 crossref_primary_10_1016_j_lanwpc_2023_100770 crossref_primary_10_1186_s12890_024_03329_7 crossref_primary_10_1371_journal_pmed_1004361 crossref_primary_10_2174_0113892037334796240927055243 crossref_primary_10_1016_S2213_2600_22_00102_3 crossref_primary_10_2217_fmb_2020_0231 crossref_primary_10_1183_16000617_0168_2024 crossref_primary_10_1016_j_ijid_2022_11_043 crossref_primary_10_1136_archdischild_2023_326151 crossref_primary_10_1016_S0140_6736_24_02479_6 crossref_primary_10_1097_HCR_0000000000000959 crossref_primary_10_1080_24745332_2023_2226003 crossref_primary_10_1038_s41467_023_41937_9 crossref_primary_10_1136_bmjopen_2023_079138 crossref_primary_10_1016_j_arbres_2025_02_007 crossref_primary_10_4081_monaldi_2025_3525 crossref_primary_10_5588_ijtldopen_23_0619 crossref_primary_10_1164_rccm_202301_0094ED crossref_primary_10_5588_ijtldopen_23_0615 crossref_primary_10_1016_S2214_109X_25_00105_6 crossref_primary_10_5588_ijtldopen_24_0093 crossref_primary_10_1016_j_ijtb_2024_10_008 crossref_primary_10_5588_ijtldopen_23_0441 crossref_primary_10_1164_rccm_202303_0430ED crossref_primary_10_1016_S2213_2600_24_00429_6 crossref_primary_10_3390_molecules28052210 crossref_primary_10_1016_j_arbres_2022_05_010 crossref_primary_10_1371_journal_pone_0290850 crossref_primary_10_1016_S1473_3099_23_00004_X crossref_primary_10_1183_13993003_02538_2021 crossref_primary_10_5588_ijtldopen_24_0530 crossref_primary_10_1016_j_eclinm_2024_102511 crossref_primary_10_1016_j_lpm_2022_104112 crossref_primary_10_1183_13993003_01881_2023 crossref_primary_10_1016_j_ijtb_2023_04_001 crossref_primary_10_1183_13993003_00765_2022 crossref_primary_10_1183_13993003_00992_2025
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.5588/ijtld.21.0425
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	1815-7920
ExternalDocumentID	34615577
Genre	Journal Article
GrantInformation_xml	– fundername: Medical Research Council grantid: MR/T040165/1 – fundername: Medical Research Council grantid: MR/K007467/1 – fundername: Wellcome Trust grantid: 201251/Z/16/Z
GroupedDBID	--- ..I 29J 2WC 5GY 5RE ACGFO ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CUY CVF DIK DU5 EBS ECM EIF EJD F5P H13 IPNFZ NPM OK1 P2P PQQKQ RIG TR2 7X8
ID	FETCH-LOGICAL-c476t-a55969b3deaaf8a7e8b0e3e60482e1e14bafafe155af6e334396e41f91d4e1372
IEDL.DBID	7X8
ISICitedReferencesCount	122
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000706090100006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1815-7920
IngestDate	Fri Jul 11 08:13:28 EDT 2025 Sat May 31 02:10:39 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	10
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c476t-a55969b3deaaf8a7e8b0e3e60482e1e14bafafe155af6e334396e41f91d4e1372
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://doi.org/10.5588/ijtld.21.0425
PMID	34615577
PQID	2580016643
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2580016643 pubmed_primary_34615577
PublicationCentury	2000
PublicationDate	2021-10-01 20211001
PublicationDateYYYYMMDD	2021-10-01
PublicationDate_xml	– month: 10 year: 2021 text: 2021-10-01 day: 01
PublicationDecade	2020
PublicationPlace	France
PublicationPlace_xml	– name: France
PublicationTitle	The international journal of tuberculosis and lung disease
PublicationTitleAlternate	Int J Tuberc Lung Dis
PublicationYear	2021
References	35768927 - Int J Tuberc Lung Dis. 2022 Jul 1;26(7):692-693. doi: 10.5588/ijtld.22.0194.
References_xml	– reference: 35768927 - Int J Tuberc Lung Dis. 2022 Jul 1;26(7):692-693. doi: 10.5588/ijtld.22.0194.
SSID	ssj0021117
Score	2.6432295
Snippet	Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide... BACKGROUND: Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	797
SubjectTerms	Consensus Humans Lung Diseases - diagnosis Lung Diseases - therapy Quality of Life Tuberculosis - complications
Title	Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
URI	https://www.ncbi.nlm.nih.gov/pubmed/34615577 https://www.proquest.com/docview/2580016643
Volume	25
WOSCitedRecordID	wos000706090100006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qinjx_VhfRPBotEnapjmJiosHd9nDCnsQlrRJYGVt12319ztpsyseBMFLT20ow2Tmm_mGbxC6YMpmTkeNaJq6AkVSkjITkCzRTBkb2EDX6vpPotdLhkPZ9w230o9VzmNiHah1kbke-TWLEgdPIIHeTN-J2xrl2FW_QmMZtThAGefVYrhgEaC2qTfuQhJzsowsaDQ2owiKvvFrNdFXjF45p_0dXdZZprP53__bQhseX-LbxiG20ZLJd9Ba1zPou-jFC4FO8LyJUGLArRhwIFYLlc5L_LYYi8HwGp79EPTGhcXToqzI4A5PIFpgT_PsoefOw-D-kfgNCyQLRVwRBfVELFOujVI2UcIkaWC4ieFaM0MNDVNllTWAOZSNDeeAXmITUiupDg3lgu2jlbzIzSHCAUvhDJbQQEVhGssklpIJGgnBuc6obKPzud1G4MGOllC5KT7K0bfl2uigMf5o2khtjHjoeFMhjv7w9TFaZ27gpJ60O0EtC_fXnKLV7LMal7Oz2jXg2et3vwB2E8RG
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+standards+for+the+assessment%2C+management+and+rehabilitation+of+post-TB+lung+disease&rft.jtitle=The+international+journal+of+tuberculosis+and+lung+disease&rft.au=Migliori%2C+G+B&rft.au=Marx%2C+F+M&rft.au=Ambrosino%2C+N&rft.au=Zampogna%2C+E&rft.date=2021-10-01&rft.eissn=1815-7920&rft.volume=25&rft.issue=10&rft.spage=797&rft_id=info:doi/10.5588%2Fijtld.21.0425&rft_id=info%3Apmid%2F34615577&rft_id=info%3Apmid%2F34615577&rft.externalDocID=34615577
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1815-7920&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1815-7920&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1815-7920&client=summon